Literature DB >> 21798395

Statin Clinical Trial (REALITY) for prostate cancer: an over 15-year wait is finally over thanks to a dietary supplement.

Mark A Moyad1, Laurence H Klotz.   

Abstract

Support for a prescription statin clinical trial for the prevention or treatment of prostate cancer has been lacking, although recent data have provoked interest in such a study. The authors have initiated a pilot trial of red yeast rice (RYR) extract and prostate cancer. RYR significantly reduces low-density lipoprotein and is an option for statin-intolerant patients. RYR appears to be an adequate proxy for some statins as long as quality control is monitored. The REALITY (REduction in Active surveillance Lipid Indices Through Yeast of red rice) trial will be conducted in Toronto, Canada.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21798395     DOI: 10.1016/j.ucl.2011.05.002

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  3 in total

Review 1.  The role of metformin, statins and diet in men on active surveillance for prostate cancer.

Authors:  Raj Tiwari; Neil Fleshner
Journal:  World J Urol       Date:  2021-10-17       Impact factor: 4.226

Review 2.  Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention.

Authors:  Mark A Moyad; Nicholas J Vogelzang
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

Review 3.  Short-term enzalutamide treatment for the potential remission of active surveillance or intermediate-risk prostate cancer: a case study, review, and the need for a clinical trial.

Authors:  Mark A Moyad; Mark C Scholz
Journal:  Res Rep Urol       Date:  2014-07-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.